<SEC-DOCUMENT>0001213900-25-061922.txt : 20250708
<SEC-HEADER>0001213900-25-061922.hdr.sgml : 20250708
<ACCEPTANCE-DATETIME>20250708084510
ACCESSION NUMBER:		0001213900-25-061922
CONFORMED SUBMISSION TYPE:	6-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20250708
FILED AS OF DATE:		20250708
DATE AS OF CHANGE:		20250708

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Cellebrite DI Ltd.
		CENTRAL INDEX KEY:			0001854587
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-PREPACKAGED SOFTWARE [7372]
		ORGANIZATION NAME:           	06 Technology
		EIN:				000000000
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		6-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-40772
		FILM NUMBER:		251109604

	BUSINESS ADDRESS:	
		STREET 1:		94 SHLOMO SHMELZER ROAD
		CITY:			PETAH TIKVA
		STATE:			L3
		ZIP:			4970602
		BUSINESS PHONE:		972 (73) 394-8000

	MAIL ADDRESS:	
		STREET 1:		94 SHLOMO SHMELZER ROAD
		CITY:			PETAH TIKVA
		STATE:			L3
		ZIP:			4970602

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Cellebrite Di Ltd.
		DATE OF NAME CHANGE:	20210331
</SEC-HEADER>
<DOCUMENT>
<TYPE>6-K
<SEQUENCE>1
<FILENAME>ea0248310-6k_cellebrite.htm
<DESCRIPTION>REPORT OF FOREIGN PRIVATE ISSUER
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 2pt solid; border-bottom: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>UNITED STATES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SECURITIES AND EXCHANGE COMMISSION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Washington, D.C. 20549</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<!-- Field: Rule-Page --><DIV STYLE="margin-left: auto; margin-right: auto; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>FORM 6-K</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<!-- Field: Rule-Page --><DIV STYLE="margin-left: auto; margin-right: auto; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Report of Foreign Private Issuer</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Pursuant to Rule 13a-16 or 15d-16</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Under the Securities Exchange Act of 1934</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>For the month of July 2025</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Commission File Number 001-40772</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<!-- Field: Rule-Page --><DIV STYLE="margin-left: auto; margin-right: auto; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Cellebrite DI Ltd.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(Translation of registrant&rsquo;s name into
English)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-left: auto; margin-right: auto; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>94 Shlomo Shmelzer Road</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Petah Tikva 4970602, Israel</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(Address of principal executive office)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-left: auto; margin-right: auto; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Indicate by check mark whether the registrant files or will file annual
reports under cover Form 20-F or Form 40-F.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Form 20-F <FONT STYLE="font-family: Times New Roman, Times, Serif">&#9746;</FONT>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Form 40-F <FONT STYLE="font-family: Times New Roman, Times, Serif">&#9744;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Rule-Page --><DIV STYLE="width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; border-bottom: Black 2pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>EXPLANATORY NOTE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="background-color: white">On July 8, 2025, Cellebrite </FONT>DI
Ltd. (the &ldquo;Registrant&rdquo; or &ldquo;Cellebrite&rdquo;) issued a press release (the &ldquo;Press Release&rdquo;) titled &ldquo;Cellebrite
Names David Barter Chief Financial Officer. CFO Dana Gerner to Retire&rdquo;. A copy of the press release is attached to this Report on
Form 6-K as Exhibit 99.1.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The first paragraph of the Press Release is incorporated
by reference into the Registrant&rsquo;s registration statements on Form S-8 (File Nos. <A HREF="http://www.sec.gov/Archives/edgar/data/1854587/000121390021057383/ea149645-s8_cellebrite.htm">333-260878</A>
and <A HREF="http://www.sec.gov/Archives/edgar/data/1854587/000121390024024537/ea0202191-s8_cellebrite.htm">333-278130</A>) filed with
the U.S. Securities and Exchange Commission (the &ldquo;SEC&rdquo;) on November 8, 2021 and March 21, 2024, respectively, and Form F-3
(File No. <A HREF="http://www.sec.gov/Archives/edgar/data/1854587/000121390022055637/posam2022a2_cellebrite.htm">333-259826</A>) filed
with the SEC on September 13, 2022, to be a part thereof from the date on which this Report on Form 6-K is submitted, to the extent not
superseded by documents or reports subsequently filed or furnished.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>EXHIBIT INDEX</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: justify; width: 9%">Exhibit</TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid; text-align: justify; width: 90%">Description</TD></TR>
  <TR STYLE="vertical-align: top; background-color: #CCEEFF">
    <TD STYLE="text-align: justify">99.1</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><A HREF="ea024831001ex99-1_cellebrite.htm">Press release titled &ldquo;Cellebrite Names David Barter Chief Financial Officer. CFO Dana Gerner to Retire&rdquo;.</A></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 3; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SIGNATURES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">Cellebrite DI Ltd.</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%"><FONT STYLE="background-color: white">Date: July 8, 2025</FONT></TD>
    <TD STYLE="width: 3%">By: </TD>
    <TD STYLE="border-bottom: black 1.5pt solid; width: 37%">/s/ <I>Ayala Berler Shapira</I></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>Ayala Berler Shapira, Adv.</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>General Counsel</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 4; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>ea024831001ex99-1_cellebrite.htm
<DESCRIPTION>PRESS RELEASE TITLED "CELLEBRITE NAMES DAVID BARTER CHIEF FINANCIAL OFFICER. CFO DANA GERNER TO RETIRE"
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; margin: 0pt 0"><B>Exhibit 99.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><IMG SRC="ex99-1_001.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Cellebrite Names David Barter Chief Financial
Officer</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><I>CFO Dana Gerner to Retire </I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><I>&nbsp;</I></B></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>TYSONS CORNER, VA and PETAH TIKVA,
ISRAEL, July 8, 2025</B> &ndash; Cellebrite (NASDAQ: CLBT), a global leader in premier Digital Investigative solutions for the
public and private sectors, today announced that David Barter, a proven finance executive with extensive public company CFO
experience in technology and software, has been appointed CFO, effective immediately. He succeeds Dana Gerner, who has served as
Cellebrite&rsquo;s CFO since 2014. Gerner will remain in an active advisory role to support the transition until the Company reports
its second-quarter 2025 financial results. As CFO, Barter is responsible for the Company&rsquo;s financial operations, including
financial planning, accounting, reporting and treasury, as well as corporate development, investor relations and operations. He
reports directly to CEO Thomas E. Hogan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&ldquo;On behalf of the full board, our employees, and our shareholders,
I want to thank Dana Gerner for her dedication, professionalism, passion and performance. For the past eleven years, Gerner led a high-caliber
finance and operations organization and played a key role in building Cellebrite into a market-leading public company, delivering consistently
strong top-line growth, profitability and cash generation,&rdquo; stated Hogan. &ldquo;The Company owes Dana an enormous debt of gratitude
and wishes her every success as she embarks on a new and exciting chapter in her life.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Hogan continued, &ldquo;We are thrilled to welcome Dave to Cellebrite.
Dana set a high bar for her successor. We sought a leader with proven experience as a public company software CFO focused on growth and
operations at scale, exceptional leadership skills, strong communication acumen and US-based with a track record of leading and operating
globally.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&ldquo;It has been a great privilege to be part of Cellebrite&rsquo;s
journey. We have accomplished a lot over the past 11 years, and the company has a bright future. I have no doubt that the team, under
Dave&rsquo;s leadership, will continue to positively contribute to Cellebrite&rsquo;s success,&rdquo; said Dana Gerner.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Barter brings more than three decades of public company financial leadership
experience. For the last 20 years, he has been focused on scaling global software companies. Prior to joining Cellebrite, he served as
CFO at&nbsp;New Relic where he played an instrumental role in driving the&nbsp;company&rsquo;s growth to nearly $1 billion in annual revenue,
transitioning the company to a consumption-based model, improving profitability and cash flow&nbsp;and supporting a successful $6.5 billion
sale of the business. Barter previously served as CFO at&nbsp;C3.ai&nbsp;and Model N as well as held senior finance positions at&nbsp;Guidewire
Software, Microsoft and General Electric. &nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&ldquo;I could not be more excited to join Cellebrite,&rdquo; stated
David Barter. &ldquo;The Company&rsquo;s unique and compelling mission and focus on public safety captured my interest and fuels my ongoing
enthusiasm about joining Cellebrite. Every day, Cellebrite&rsquo;s technology makes a&nbsp;tangible difference in helping thousands of
customers around the globe elevate their operational intelligence and accelerate their investigations in ways that make our world safer.
I look forward to working with&nbsp;Cellebrite&rsquo;s leadership team as well as my new colleagues to effectively and efficiently&nbsp;expand
our business around the world and deliver on our commitments to our customers, communities, employees and&nbsp;shareholders.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Second-Quarter 2025 Financial Results Date and Related Conference
Call and Webcast </I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Cellebrite
will report its second-quarter 2025 financial results before market open on Thursday, August 14, 2025. Later that same morning, Cellebrite
will host a live conference call and webcast to review the Company's quarterly financial results, introduce Dave Barter and provide an
update on important strategic initiatives including the recently announced acquisition of Corellium.</FONT><FONT STYLE="font-size: 10pt">&nbsp;</FONT>
<FONT STYLE="font-family: Times New Roman, Times, Serif">Relevant details include:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"></FONT>&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 20%"><FONT STYLE="font-family: Times New Roman, Times, Serif">Date:</FONT></TD>
    <TD STYLE="width: 80%"><FONT STYLE="font-family: Times New Roman, Times, Serif">Thursday, August 14, 2025</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Time:</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">8:30 a.m. ET</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Call-In Number:</FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">203-518-9783 / 800-267-6316</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Conference ID: </FONT></TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">CLBTQ225</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Event URL:</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">https://investors.cellebrite.com/events/event-details/cellebrite-q2-2025-financial-results-conference-call-webcast&nbsp;&nbsp;&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Live Webcast URL:</FONT></TD>
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">https://edge.media-server.com/mmc/p/8rnat9mu/</P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">In conjunction with the conference call and webcast, historical financial
tables and supplemental data will be available on the quarterly results section of Company&rsquo;s investor relations website at https://investors.cellebrite.com/financial-information/quarterly-results.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><B>References to Websites and Social Media
Platforms</B></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><BR>
References to information included on, or accessible through, websites and social media platforms do not constitute incorporation by reference
of the information contained at or available through such websites or social media platforms, and you should not consider such information
to be part of this press release.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><B>About Cellebrite</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><B>&nbsp;</B></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">Cellebrite&rsquo;s (Nasdaq: CLBT) mission
is to enable its global customers to protect and save lives by enhancing digital investigations and intelligence gathering to accelerate
justice in communities around the world. Cellebrite&rsquo;s AI-powered Digital Investigation Platform enables customers to lawfully access,
collect, analyze and share digital evidence in legally sanctioned investigations while preserving data privacy. Thousands of public safety
organizations, intelligence agencies, and businesses rely on Cellebrite&rsquo;s digital forensic and investigative solutions&mdash;available
via cloud, on-premises, and hybrid deployments&mdash;to close cases faster and safeguard communities.<FONT STYLE="background-color: white">&nbsp;</FONT>To
learn more, visit us at www.cellebrite.com,&nbsp;https://investors.cellebrite.com/investors and find us on social media @Cellebrite.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Caution Regarding Forward Looking Statements</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">This document includes &ldquo;forward-looking statements&rdquo; within
the meaning of the &ldquo;safe harbor&rdquo; provisions of the United States Private Securities Litigation Reform Act of 1995. Forward
looking statements may be identified by the use of words such as &ldquo;forecast,&rdquo; &ldquo;intend,&rdquo; &ldquo;seek,&rdquo; &ldquo;target,&rdquo;
&ldquo;anticipate,&rdquo; &ldquo;will,&rdquo; &ldquo;appear,&rdquo; &ldquo;approximate,&rdquo; &ldquo;foresee,&rdquo; &ldquo;might,&rdquo;
&ldquo;possible,&rdquo; &ldquo;potential,&rdquo; &ldquo;believe,&rdquo; &ldquo;could,&rdquo; &ldquo;predict,&rdquo; &ldquo;should,&rdquo;
&ldquo;could,&rdquo; &ldquo;continue,&rdquo; &ldquo;expect,&rdquo; &ldquo;estimate,&rdquo; &ldquo;may,&rdquo; &ldquo;plan,&rdquo; &ldquo;outlook,&rdquo;
&ldquo;future&rdquo; and &ldquo;project&rdquo; and other similar expressions that predict, project or indicate future events or trends
or that are not statements of historical matters. A number of factors could cause actual results or outcomes to differ materially from
those indicated by such forward-looking statements. These factors include, but are not limited to: Successful completion of the Company&rsquo;s
quarterly financial close processes and the successful transition of the CFO role at the Company; Cellebrite&rsquo;s ability to keep pace
with technological advances and evolving industry standards; Cellebrite&rsquo;s material dependence on the purchase, acceptance and use
of its solutions by law enforcement and government agencies; real or perceived errors, failures, defects or bugs in Cellebrite&rsquo;s
DI solutions; Cellebrite&rsquo;s failure to maintain the productivity of sales and marketing personnel, including relating to hiring,
integrating and retaining personnel; intense competition in all of Cellebrite&rsquo;s markets; the inadvertent or deliberate misuse of
Cellebrite&rsquo;s solutions; failure to manage its growth effectively; Cellebrite&rsquo;s ability to introduce new solutions and add-ons;
its dependency on its customers renewing their subscriptions; the low volume of business Cellebrite conducts via e-commerce; risks associated
with the use of artificial intelligence; the risk of requiring additional capital to support the growth of its business; risks associated
with higher costs or unavailability of materials used to create its hardware product components; fluctuations in foreign currency exchange
rates; lengthy sales cycle for some of Cellebrite&rsquo;s solutions; near term declines in new or renewed agreements; risks associated
with inability to retain qualified personnel and senior management; the security of Cellebrite&rsquo;s operations and the integrity of
its software solutions; risks associated with the negative publicity related to Cellebrite&rsquo;s business and use of its products; risks
related to Cellebrite&rsquo;s intellectual property; the regulatory constraints to which Cellebrite is subject; risks associated with
Cellebrite&rsquo;s operations in Israel, including the ongoing Israel-Hamas war and the risk of a greater regional conflict; risks associated
with different corporate governance requirements applicable to Israeli companies and risks associated with being a foreign private issuer
and an emerging growth company; market volatility in the price of Cellebrite&rsquo;s shares; changing tax laws and regulations; risks
associated with joint, ventures, partnerships and strategic initiatives; risks associated with Cellebrite&rsquo;s significant international
operations; risks associated with Cellebrite&rsquo;s failure to comply with anti-corruption, trade compliance, anti-money-laundering and
economic sanctions laws and regulations; risks relating to the adequacy of Cellebrite&rsquo;s existing systems, processes, policies, procedures,
internal controls and personnel for Cellebrite&rsquo;s current and future operations and reporting needs; and other factors, risks and
uncertainties set forth in the section titled &ldquo;Risk Factors&rdquo; in Cellebrite&rsquo;s annual report on Form 20-F filed with the
SEC on March 18, 2025, and in other documents filed by Cellebrite with the U.S. Securities and Exchange
Commission (&ldquo;SEC&rdquo;), which are available free of charge at www.sec.gov. You are cautioned not to place undue reliance upon
any forward-looking statements, which speak only as of the date made, in this communication or elsewhere. Cellebrite undertakes no obligation
to update its forward-looking statements, whether as a result of new information, future developments or otherwise, should circumstances
change, except as otherwise required by securities and other applicable laws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Contacts:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Investors Relations</B><BR>
Andrew Kramer</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Vice President, Investor Relations</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">investors@cellebrite.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">+1 973.206.7760</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Media </B><BR>
Jackie Labrecque</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Sr. Manager of Content Strategy and Operations</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Jackie.labrecque@cellebrite.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">+1 771.241.7010</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">3</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>




</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>ex99-1_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex99-1_001.jpg
M_]C_X  02D9)1@ ! 0$ > !X  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1"  T /\# 2(  A$! Q$!_\0
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M/89YKR?]D_\ :]\7?'3XDR^']<T_2[6S73Y+H/9QNK[E90!RQX^8UL_LS?\
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M;(BXVJFX8P1CFO!_@;^TEXO\5?M(:9X;OH=&73I=1N(6:#3(HY=JA\8<#(/
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M=P.>O;%;1LZ6US&5U4WL?.WQ\^*.G?%KXD7?BS2-%;P]]HBC,MOO#EIEZR9
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MA[R=(;5H6*R[F+@A@,#C/7'2OFKXX:5=?!+]JK4=2O=/6[M%U8:O##.@,=S
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4N![DGJ2>Y/)HHJJTF[7)I):G_]D!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
